D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The study will determine the effects of D-Cycloserine (DCS) on fear reduction in patients
diagnosed with phobia of heights (acrophobia) undergoing one session of three hours of
virtual reality exposure therapy (VRET) or in vivo exposure therapy (IVET).